期刊文献+

Polarization of M1 tumor associated macrophage promoted by the activation of TLR3 signal pathway 被引量:6

Polarization of M1 tumor associated macrophage promoted by the activation of TLR3 signal pathway
下载PDF
导出
摘要 Objective: To investigate the correlation between activation of toll-like receptors 3(TLR3) signaling pathway and tumor-associated macrophage and its effect on the tumor growth. Methods: The mice Lewis lung cancer cell lines 3LL and melanoma B16H10 were used to construct the subcutaneous transplantation tumor models and then they were treated with Poly-ICLC. The curative effect was observed and then the T cell and macrophage phenotypes infiltrated in local tumor were detected by flow cytometry. After the in vitro culture of mouse bone marrow-derived macrophage, the real-time PCR and western blot were applied to detect the expression of macrophage activation markers and the activation of intracellular signaling pathways. Results: The survival time of mice with brown tumor treated with Poly-ICLC significantly increased and the tumor growth was inhibited. The ratio of local tumor-infiltrated Treg decreased, while the ratio of CD8+ T cell increased significantly. The macrophages surface CD206 expression was down-regulated while the expression of i NOS increased. The Poly-ICLC could promote the expression of M1 markers(IL-1毬, TNF-α毩 and i NOS) in bone marrow-derived macrophage and inhibited the expression of M2 molecules(Arg-1, YM-1 and CD206). The phosphorylation level of downstream p65, TBK1 and IRF3 increased significantly. Conclusions: The Poly-ICLC can activate the TLR3 downstream signaling pathway to induce a M1 polarization of tumor associated macrophage, thereby inhibiting the tumor growth. Objective: To investigate the correlation between activation of toll-like receptors 3 (TLR3) signaling pathway and tumor-associated macrophage and its effect on the tumor growth. Methods: The mice Lewis lung cancer cell lines 3LL and melanoma B 16H10 were used to construct the subcutaneous transplantation tumor models and then they were treated with Poly-ICLC. The curative effect was observed and then the T cell and macrophage phenotypes infiltrated in local tumor were detected by flow cytometry. After the in vitro culture of mouse bone marrow-derived macrophage, the real-time PCR and western blot were applied to detect the expression of macrophage activation markers and the activation of intracellular signaling pathways. Results: The survival time of mice with brown tumor treated with Poly-ICLC significantly increased and the tumor growth was inhibited. The ratio of local tumor-infiltrated Treg decreased, while the ratio of CD8(+) T cell increased significantly. The macrophages surface CD206 expression was down-regulated while the expression of iNOS increased. The Poly-ICLC could promote the expression of Ml markers (IL-I (3, TNF-alpha and iNOS) in bone marrow-derived macrophage and inhibited the expression of M2 molecules (Arg-1, YM-1 and CD206). The phosphorylation level of downstream p65, TBK1 and IRF3 increased significantly. Conclusions: The Poly-ICLC can activate the TLR3 downstream signaling pathway to induce a M1 polarization of tumor associated macrophage, thereby inhibiting the tumor growth.
出处 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第5期470-474,共5页 亚太热带医药杂志(英文版)
基金 supported by Natural Science Foundation Project of Yongchuan District of Chongqing(Gran No.YCSTC2015nc5026)
关键词 TUMOR-ASSOCIATED MACROPHAGE TLR3 Poly-ICLC M1 Tumor-associated macrophage TLR3 Poly-ICLC M1
  • 相关文献

参考文献18

  • 1Ho V,Lim TS,Lee J,Steinberg J,Szmyd R,Tham M,et al.TLR3agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression. Oncotarget . 2015 被引量:1
  • 2Martins KA,Bavari S,Salazar AM.Vaccine adjuvant uses of poly-IC and derivatives. Expert Review of Vaccines . 2015 被引量:1
  • 3Salazar AM,Erlich RB,Mark A,Bhardwaj N,Herberman RB.Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC:case report,hypothesis,and clinical trial. Cancer Immunol Res . 2014 被引量:1
  • 4Cui R,Shi XY.Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value. Int J Clin Exp Pathol . 2015 被引量:1
  • 5Rosenfeld Myrna R,Chamberlain Marc C,Grossman Stuart A,Peereboom David M,Lesser Glenn J,Batchelor Tracy T,Desideri Serena,Salazar Andres M,Ye Xiaobu.A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma. Neuro oncology . 2010 被引量:1
  • 6Martins A,Steffens T,van Tongeren A,et al.Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation. PLoS One . 2014 被引量:1
  • 7Becker M,Müller CB,De Bastiani MA,et al.The prognostic impact of tumor-associated macrophages and intra-tumoral apoptosis in nonsmall cell lung cancer. Histology and Histopathology . 2014 被引量:1
  • 8Komura T,Sakai Y,Harada K, et al.In lammatory Features of Pancreatic Cancer Highlighted by Monocytes/Macrophages and CD4+T cells with Clinical Impact. Cancer Science . 2015 被引量:1
  • 9Stuart A. Grossman,Xiaobu Ye,Steven Piantadosi,Serena Desideri,Louis B. Nabors,Myrna Rosenfeld,Joy Fisher,for the NABTT CNS Consorti.Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States. Clinical Cancer Research . 2010 被引量:1
  • 10Sylvia Adams.??Toll-like receptor agonists in cancer therapy(J)Immunotherapy . 2009 (6) 被引量:1

同被引文献72

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部